National Bank of Canada’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.8M | Buy |
+735,600
| New | +$35.8M | 0.03% | 319 |
|
|
2024
Q3 | – | Sell |
-848
| Closed | -$45.6K | – | 2615 |
|
|
2024
Q2 | $45.6K | Buy |
848
+220
| +35% | +$11.8K | ﹤0.01% | 1565 |
|
|
2024
Q1 | $32.1K | Sell |
628
-40
| -6% | -$2.04K | ﹤0.01% | 1711 |
|
|
2023
Q4 | $44.1K | Sell |
668
-1,170
| -64% | -$77.2K | ﹤0.01% | 1640 |
|
|
2023
Q3 | $77.7K | Buy |
1,838
+445
| +32% | +$18.8K | ﹤0.01% | 1471 |
|
|
2023
Q2 | $78.2K | Sell |
1,393
-80
| -5% | -$4.49K | ﹤0.01% | 1499 |
|
|
2023
Q1 | $66.6K | Sell |
1,473
-6
| -0.4% | -$271 | ﹤0.01% | 1499 |
|
|
2022
Q4 | $60.1K | Sell |
1,479
-250
| -14% | -$10.2K | ﹤0.01% | 1538 |
|
|
2022
Q3 | $112K | Buy |
1,729
+536
| +45% | +$34.7K | ﹤0.01% | 1343 |
|
|
2022
Q2 | $73K | Sell |
1,193
-441
| -27% | -$27K | ﹤0.01% | 1457 |
|
|
2022
Q1 | $101K | Buy |
1,634
+476
| +41% | +$29.4K | ﹤0.01% | 1438 |
|
|
2021
Q4 | $88K | Buy |
+1,158
| New | +$88K | ﹤0.01% | 1461 |
|